Corneal Collagen Crosslinking with Riboflavin and Ultraviolet - A Irradiation in the Management of Progressive Ectatic Corneal Disorders. Review Article | ||||
| Journal of Ophthalmology and Related Sciences | ||||
| Article 2, Volume 1, Issue 1, July 2017, Page 15-30 PDF (290.7 K) | ||||
| Document Type: Review Articles | ||||
| DOI: 10.21608/jors.2017.3598 | ||||
 View on SCiNiTO | ||||
| Author | ||||
| Mostafa Salah Eldine | ||||
| Refractive Unit, Department of Ophthalmology, Research Institute of Ophthalmology, Egypt | ||||
| Abstract | ||||
| Corneal crosslinking (CXL) has been proposed as a new modality to stop progression of keratoconus or secondary corneal ectasia, aiming to prevent progressive visual loss and to delay or avoid corneal transplantation. The possibility of strengthening corneal tissue by means of a photochemical reaction of corneal collagen by the combined action of riboflavin and ultravioletA irradiation (UVA), radically modified the conservative management of progressive corneal ectasia. This is a review of the state of the art of CXL. The paper describes basic principles, advantages and limitations of different CXL techniques and possible future evolution of the procedure. | ||||
| Keywords | ||||
| Keratoconus, ectasia, collagen cross-linking, epithelium-off collagen corneal crosslinking; epithelium-on, transepithelial cross-linking | ||||
|
Statistics Article View: 286 PDF Download: 412 |
||||
